
US-based Lumen Biomedical Inc. specializes in thrombus removal devices and vaccine production.
Lumen Biomedical Inc., headquartered in the United States, was founded with a core mission to innovate in the medical device and biotechnology sectors. The company specializes in the development and production of thrombus removal devices, which are critical for treating blood clots, as well as bacterial and virus vaccines. Lumen Biomedical aims to enhance patient outcomes through advanced medical technologies and solutions, focusing on both the healthcare and biotechnology markets.
Notable figures associated with Lumen Biomedical include key industry professionals and investors who have supported the company's growth and innovation. The company has achieved significant milestones in the development of its thrombus removal devices, contributing to improved medical procedures and patient care. Lumen Biomedical's impact is evident in its contributions to medical technology advancements and its role in addressing critical healthcare needs.

Lumen Bioscience

eLum Technologies

Bi02 Medical
bio2medical.com

LumiThera
lumithera.com

EmboMedics

i-Lumen Scientific
i-lumen.com

Micron Biomedical

BioLum Sciences
biolumsciences.com

Luma Therapeutics

Alucent Biomedical
alucentmedical.com

Halcyon Biomedical

Luminous Medical

Biophyx
biophyx.co

BiomedInnovations

International Biomedical Devices
aperturectc.com
Companies similar to Lumen Biomedical include Lumen Bioscience, eLum Technologies, Bi02 Medical and LumiThera.
Lumen Biomedical was founded in 2003.
Lumen Biomedical's headquarters is located in Maple Grove, MN, US.
Lumen Biomedical's most recent funding round was for $675k (USD) in October 2009.
As of Oct 10, 2009, Lumen Biomedical has raised a total of $675k (USD).
Lumen Biomedical has 11 employees as of Feb 5, 2024.